4//SEC Filing
Colleran David 4
Accession 0001171843-25-001405
CIK 0000898437other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:17 PM ET
Size
9.5 KB
Accession
0001171843-25-001405
Insider Transaction Report
Form 4
Colleran David
EVP, General Counsel, Corp Sec
Transactions
- Tax Payment
Common Stock
2025-03-10$16.62/sh−1,604$26,658→ 37,986 total - Exercise/Conversion
Restricted Stock Unit
2025-03-10−5,465→ 5,465 totalExercise: $0.00→ Common Stock (5,465 underlying) - Exercise/Conversion
Common Stock
2025-03-10+5,465→ 39,590 total
Footnotes (5)
- [F1]Reflects the second vesting installment of RSUs granted on March 9, 2023.
- [F2]Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024.
- [F3]Reflects an aggregate of 1,604 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025.
- [F4]Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001646558
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:17 PM ET
- Size
- 9.5 KB